Abstract:Objective: To analyze the genotypes and phenotypes of mosaic male patients with PCDH19-related epilepsy (PCDH19-RE) and explore the correlation between genotype, variant allele frequency (VAF), and phenotypic severity. Methods: Clinical data and peripheral blood samples of 11 male mosaic patients were collected and analyzed in our study. The VAF of the PCDH19 gene from peripheral blood was quantified using amplicon-based deep sequencing. Additional 20 mosaic male patients with PCDH19-RE were collected from the published literature, with 10 patients whose VAFs of the PCDH19 gene were available for analytic purposes. Results: In our cohort of 11 patients, 10 variants were identified, and four were novel. The VAF of the PCDH19 gene from peripheral blood ranged from 27 to 90%. The median seizure onset age was 6 months (range: 4-9 months). Clinical manifestations included cluster seizures (100%), fever sensitivity (73%), focal seizures (91%), developmental delay/intellectual disability (DD/ID, 82%), and autistic features (45%). Thirty-one mosaic male patients collected from our cohort and the literature developed seizures mostly (87%) within one year of age. Variant types included missense variants (42%), truncating variants (52%), splice variants (3%), and whole PCDH19 deletion (3%). Among 21 patients with a definite VAF from our cohort and the literature, nine had a low VAF ( ≤ 50%) and 12 had a high VAF (> 50%). Seventy-five percent of variants from the high VAF group were missense, whereas 89% of those from the low VAF group were truncations. The median seizure onset age was 6 months in the low VAF group and 9 months in the high VAF group (p = 0.018). Forty-four percent (4/9) of patients from the low VAF group achieved seizure-free for ≥1 year, whereas none of the 12 patients from the high VAF group did (p = 0.021). DD/ID was present in 83% (10/12) of the high VAF group and 56% (5/9) of the low VAF group (p = 0.331). Conclusion: The predominant variant types were truncating and missense variants. Missense variants tended to have higher VAFs. Patients with a high VAF were more likely to have a more severe epileptic phenotype. Our findings shed light on the phenotypic implications of VAF in mosaic males with PCDH19-RE.

PCDH19 in Males: Are Hemizygous Variants Linked to Autism?

Autism Spectrum Disorder Early in Development Associated with CHD8 Mutations among Two Chinese Children

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder

Common genetic variants on 5p14.1 associate with autism spectrum disorders

A new case with coexistence of mosaic 48,XYYY/47,XYY, and CACNA1E variant in autism spectrum disorder

Mosaicism and Incomplete Penetrance of PCDH19 Mutations.

Rare pathogenic variants identified in whole exome sequencing of monozygotic twins with autism spectrum disorders

Chromosome X-Wide Common Variant Association Study (XWAS) in Autism Spectrum Disorder

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders

PCDH19-related epilepsy in mosaic males: The phenotypic implication of genotype and variant allele frequency

A Sex-Specific Association of Common Variants of Neuroligin Genes (NLGN3 and NLGN4X) with Autism Spectrum Disorders in a Chinese Han Cohort

De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth

Genotype–phenotype Analysis of 18Q12.1-Q12.2 Copy Number Variation in Autism

The genetic landscape of autism spectrum disorder in the Middle Eastern population

Association of ABCA13 Gene Variants with Autism Spectrum Disorder and Other Neuropsychiatric Disorders

Autism-Linked Mutations in α2δ-1 and α2δ-3 Reduce Protein Membrane Expression but Affect Neither Calcium Channels nor Trans-Synaptic Signaling

A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity

Identifying Rare Genetic Variants of Immune Mediators As Risk Factors for Autism Spectrum Disorder

An Intronic Variant of CHD7 Identified in Autism Patients Interferes with Neuronal Differentiation and Development.

Rare Maternally Inherited Coding Variants on Chromosome X Carry Predominantly Male Risk in Autism, Tourette Syndrome, and Attention-deficit/Hyperactivity Disorder